NCT02586207 2025-10-07
Pembrolizumab in Combination With CRT for LA-SCCHN
Sanford Health
Phase 1 Completed
Sanford Health
Thomas Jefferson University
Al-Maarif University College
National Cancer Centre, Singapore
Emory University
University of Maryland, Baltimore
The Netherlands Cancer Institute
Dana-Farber Cancer Institute
Sanofi
AHS Cancer Control Alberta